Improving surgical performance with innovative tissue regeneration solutions from the Nordics.
At Biomendex, our mission is to give surgeons the freedom to operate and concentrate on what is most important: the patient.
We believe that our innovative and versatile bone graft substitutes can provide improvements in surgical outcomes and minimize operational risks.
Biomendex develops Adaptos® bone graft substitutes for various surgical segments including spinal fusion, oral and maxillofacial and orthopedic indications. Adaptos®Vet is already commercially available for veterinary surgeries.
Adaptable solutions for the whole human skeletal system are in the premarket phase.
Adaptos® bone graft substitutes are easy to shape and use even in demanding operations. Adaptos® products are being developed for various surgical indications, including oral & maxillofacial, orthopedic, and spine.
The first truly adaptive bone graft for veterinaries is commercially available.
Adaptos®Vet products enable superior handling qualities and operational performance for veterinary surgeons. Our Adaptos®Vet products are already globally available for treatment of veterinary patients, and have been delivered to over 2000 veterinary surgeries without complaints.
See the latest updates about Biomendex.
The first patients have been operated in United States with our FDA 510(k) cleared Adaptos®Fuse. The preliminary feedback have been encouraging and Mayo Clinic is now expanding the use of Adaptos(R)Fuse in various neuro and…
Read more »Tampere, Finland — 18-Feb, 2026 Biomendex today announced that Adaptos® Fuse Bone Graft has received U.S. Food and Drug Administration (FDA) 510(k) clearance as a bone graft substitute for filling bony voids or gaps that…
Read more »We’re thrilled to share that Adaptos®Vet is now available in Australia and New Zealand through Sound Veterinary Equipment. This means easier access to a product designed for enhanced handling, resilience, and seamless osseointegration in veterinary surgeries. Whether…
Read more »
Adaptos® adaptable bone graft substitutes provide synthetic solutions for the whole skeletal system. The unique composite material of Adaptos® is a combination of the best structural and functional features of both gel-like and ceramic bone graft substitutes.
With high level of bioactivity and press-fit implantation, Adaptos® locks in its place during implantation and integrates into bone tissue through natural bonding. Natural bone-like structure and optimal porosity enable tissue ingrowth and bone formation inside the material, which are essential for bone regeneration.
Adaptos® is the first bioactive bone graft substitute that surgeons can cut, shape, squeeze, and pack into place. It is the only bone graft substitute that mimics bone by being resilient and has durable structure that recovers after compression.
Adaptos® is squeezable, and it stretches. Unbreakable material is designed to perform even in toughest spots.
Shape it as you wish. Adaptos® will not break or crumble under the strain.
Cut Adaptos® with scissors to fit any shape.
Resilient and elastic Adaptos® can be packed to fill even the smallest voids.
Adaptos® bone graft substitutes are being developed for various surgical indications, including oral & maxillofacial, orthopedic and spine. Adaptos®Vet products are already available for veterinary surgeries.
Interested in distributor partnership for Adaptos®Vet?
Adaptos®Vet is Biomendex’s highly competitive adaptable bone graft substitute product line for veterinarians. We are currently open for new distributor proposals.
If you have the industry experience and insight, great client network and the pioneer mindset that is needed to launch new products in your market, please contact us for more information.
Groundbreaking technology at your fingertips
Biomendex is currently carrying out several studies in collaboration with its research partners. Our partners include major medical and vet service providers, such as Helsinki University Hospital and Pihlajalinna Oy, Mayo Clinic, Wake Forest Institute of Renerative Medicine and Evidensia.
Interested in research partnerships with Biomendex, please contact the Biomendex team for more information.